Dennis Karl Huang's most recent trade in Ultragenyx Pharmaceutical Inc. was a trade of 26,074 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 26,074 | 26,074 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 18,443 | 115,939 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 14,494 | 97,496 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.92 per share. | 01 Mar 2025 | 1,348 | 114,591 (0%) | 0% | 42.9 | 57,856 | Common Stock |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 31,400 | 31,400 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 17,800 | 82,515 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 957 | 83,472 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.69 per share. | 01 Mar 2024 | 470 | 83,002 (0%) | 0% | 53.7 | 25,234 | Common Stock |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 39,400 | 39,400 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 22,000 | 75,703 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Sale or transfer of securities back to the company at price $ 45.65 per share. | 01 Mar 2023 | 10,599 | 64,715 (0%) | 0% | 45.6 | 483,844 | Common Stock |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,663 | 53,703 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Sale of securities on an exchange or to another person at price $ 45.65 per share. | 01 Mar 2023 | 389 | 75,314 (0%) | 0% | 45.7 | 17,758 | Common Stock |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 24,900 | 24,900 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 14,000 | 51,040 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | See Remarks | Sale of securities on an exchange or to another person at price $ 66.62 per share. | 01 Mar 2022 | 3,234 | 36,914 (0%) | 0% | 66.6 | 215,449 | Common Stock |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | EVP & Chief Tech Ops Officer | Sale of securities on an exchange or to another person at price $ 81.14 per share. | 14 Oct 2021 | 358 | 40,148 (0%) | 0% | 81.1 | 29,048 | Common Stock |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | EVP & Chief Tech Ops Officer | Sale of securities on an exchange or to another person at price $ 113.68 per share. | 06 May 2021 | 363 | 40,506 (0%) | 0% | 113.7 | 41,266 | Common Stock |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | EVP & Chief Tech Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | EVP & Chief Tech Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 5,500 | 40,199 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | EVP & Chief Tech Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 4,636 | 44,835 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | EVP & Chief Tech Ops Officer | Sale of securities on an exchange or to another person at price $ 138.18 per share. | 01 Mar 2021 | 4,255 | 40,761 (0%) | 0% | 138.2 | 587,956 | Common Stock |
| Ultragenyx Pharmaceutical ... | Dennis Karl Huang | EVP & Chief Tech Ops Officer | Sale of securities on an exchange or to another person at price $ 88.00 per share. | 14 Oct 2020 | 262 | 34,699 (0%) | 0% | 88 | 23,056 | Common Stock |